Cancer Research AACR Membership  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 2750-2757, June 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hursting, S. D.
Right arrow Articles by Kari, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hursting, S. D.
Right arrow Articles by Kari, F. W.

The Growth Hormone: Insulin-like Growth Factor 1 Axis Is a Mediator of Diet Restriction-induced Inhibition of Mononuclear Cell Leukemia in Fischer Rats1

Stephen D. Hursting2, Boyd R. Switzer, John E. French and Frank W. Kari3

Department of Nutrition [S. D. H., B. R. S., F. W. K.], University of North Carolina, Chapel Hill, North Carolina 27599, and National Institute of Environmental Health Sciences [S. D. H., J. E. F., F. W. K.], NIH, Research Triangle Park, North Carolina 27709

A leukemia cell transplant model and both in situ and in vitro bioassays were used to assess the roles of endogenous factors in mediating diet restriction (DR)-induced inhibition of mononuclear cell leukemia (MNCL) in Fischer 344 rats. DR-treated male rats (n = 35), which were fed 75% of ad libitum (AL) intake of NIH-07 open formula diet, had lower transplanted MNCL incidence (54 versus 77%; P = 0.039) with longer latency (P = 0.015) and decreased severity (P = 0.01) than AL-treated rats 12 weeks after inoculation with MNCL cells. Five-day proliferation rates of cultured MNCL (CRNK-16) cells in diffusion chambers implanted in DR-treated rats were 22% less than in AL-treated rats (P = 0.03), indicating that DR-dependent diffusible factor(s) modulate in situ MNCL cell growth. Serum from DR-treated rats supported lower in vitro CRNK-16 cell proliferation rates relative to serum from AL-treated rats. Serum levels of both growth hormone (GH) and insulin-like growth factor 1 (IGF-1) were over 50% lower in DR-versus AL-treated rats. An evaluation of the in vitro cell proliferative activity of a panel of purified factors showed that GH and IGF-1, but not 15 other growth factors, stimulated thymidine incorporation in CRNK-16 cells. Infusion of either GH or IGF-1 via osmotic minipumps restored in situ and in vitro CRNK-16 cell proliferation in DR-treated rats up to rates measured in AL-treated rats. Splenocytes from DR-treated rats, relative to AL-treated rats, were more sensitive to mitogen stimulation, displayed increased cell surface expression of receptors for class 1 and 2 major histocompatibility complex molecules, and were more cytotoxic to target tumor cells. Infusion of either GH or IGF-1 in DR-treated rats further enhanced mitogen responsiveness and natural cytotoxicity but reversed the DR-induced increase in major histocompatibility complex receptors. We conclude that DR modulates MNCL progression in Fischer 344 rats through both its influence on MNCL cell proliferation via suppression of the GH:IGF-1 axis and its enhancement of host defenses against tumor cells.

1 This work is part of a dissertation submitted to the Graduate School, University of North Carolina-Chapel Hill, in partial fulfillment toward requirements for the Ph.D. degree [S. D. H]

2 Present address: Laboratory of Nutritional and Molecular Regulation, National Cancer Institute, NIH, Frederick Cancer Research Center, Frederick, MD 21701.

3 To whom requests for reprints should be addressed.

Received 11/ 2/92. Accepted 4/ 7/93.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
T. Moore, L. Beltran, S. Carbajal, S. Strom, J. Traag, S. D. Hursting, and J. DiGiovanni
Dietary Energy Balance Modulates Signaling through the Akt/Mammalian Target of Rapamycin Pathways in Multiple Epithelial Tissues
Cancer Prevention Research, June 1, 2008; 1(1): 65 - 76.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Moore, S. Carbajal, L. Beltran, S. N. Perkins, S. Yakar, D. LeRoith, S. D. Hursting, and J. DiGiovanni
Reduced Susceptibility to Two-Stage Skin Carcinogenesis in Mice with Low Circulating Insulin-Like Growth Factor I Levels
Cancer Res., May 15, 2008; 68(10): 3680 - 3688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Xie, Y. Jiang, P. Ouyang, J. Chen, H. Doan, B. Herndon, J. E. Sylvester, K. Zhang, A. Molteni, M. Reichle, et al.
Effects of Dietary Calorie Restriction or Exercise on the PI3K and Ras Signaling Pathways in the Skin of Mice
J. Biol. Chem., September 21, 2007; 282(38): 28025 - 28035.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Thomas, J. K. Haseman, J. I. Goodman, J. M. Ward, T. P. Loughran Jr, and P. J. Spencer
A Review of Large Granular Lymphocytic Leukemia in Fischer 344 Rats as an Initial Step Toward Evaluating the Implication of the Endpoint to Human Cancer Risk Assessment
Toxicol. Sci., September 1, 2007; 99(1): 3 - 19.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Endocr. Rev., February 1, 2007; 28(1): 20 - 47.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. M. Huffman, M. S. Johnson, A. Watts, A. Elgavish, I. A. Eltoum, and T. R. Nagy
Cancer Progression in the Transgenic Adenocarcinoma of Mouse Prostate Mouse Is Related to Energy Balance, Body Mass, and Body Composition, but not Food Intake
Cancer Res., January 1, 2007; 67(1): 417 - 424.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Yakar, N. P. Nunez, P. Pennisi, P. Brodt, H. Sun, L. Fallavollita, H. Zhao, L. Scavo, R. Novosyadlyy, N. Kurshan, et al.
Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones
Endocrinology, December 1, 2006; 147(12): 5826 - 5834.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. A. Hsieh, C. M. Chai, and M. K. Hellerstein
Effects of caloric restriction on cell proliferation in several tissues in mice: role of intermittent feeding
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E965 - E972.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. C. Patel, N. P. Nunez, S. N. Perkins, J. C. Barrett, and S. D. Hursting
Effects of Energy Balance on Cancer in Genetically Altered Mice
J. Nutr., December 1, 2004; 134(12): 3394S - 3398S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. D. Hursting, J. A. Lavigne, D. Berrigan, L. A. Donehower, B. J. Davis, J. M. Phang, J. C. Barrett, and S. N. Perkins
Diet-Gene Interactions in p53-Deficient Mice: Insulin-like Growth Factor-1 as a Mechanistic Target
J. Nutr., September 1, 2004; 134(9): 2482S - 2486S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D. Holmes, M. N. Pollak, and S. E. Hankinson
Lifestyle Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 862 - 867.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
R. L. Walford, D. Mock, R. Verdery, and T. MacCallum
Calorie Restriction in Biosphere 2: Alterations in Physiologic, Hematologic, Hormonal, and Biochemical Parameters in Humans Restricted for a 2-Year Period
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2002; 57(6): B211 - 224.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
D. Berrigan, S. N. Perkins, D. C. Haines, and S. D. Hursting
Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice
Carcinogenesis, May 1, 2002; 23(5): 817 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. D. Hursting, S. N. Perkins, J. M. Phang, and J. C. Barrett
Diet and Cancer Prevention Studies in p53-Deficient Mice
J. Nutr., November 1, 2001; 131(11): 3092S - 3094.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Giovannucci
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
J. Nutr., November 1, 2001; 131(11): 3109S - 3120.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Przybyszewski, A. L. Yaktine, E. Duysen, D. Blackwood, W. Wang, A. Au, and D. F. Birt
Inhibition of phorbol ester-induced AP-1-DNA binding, c-Jun protein and c-jun mRNA by dietary energy restriction is reversed by adrenalectomy in SENCAR mouse epidermis
Carcinogenesis, September 1, 2001; 22(9): 1421 - 1427.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
S. D. Hursting, S. N. Perkins, L. A. Donehower, and B. J. Davis
Cancer Prevention Studies in p53-Deficient Mice
Toxicol Pathol, January 1, 2001; 29(1): 137 - 141.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Endocr. Rev., June 1, 2000; 21(3): 215 - 244.
[Abstract] [Full Text]


Home page
BloodHome page
W. Zumkeller and S. Burdach
The Insulin-Like Growth Factor System in Normal and Malignant Hematopoietic Cells
Blood, December 1, 1999; 94(11): 3653 - 3657.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. Mukherjee, A. V. Sotnikov, H. J. Mangian, J.-R. Zhou, W. J. Visek, and S. K. Clinton
Energy Intake and Prostate Tumor Growth, Angiogenesis, and Vascular Endothelial Growth Factor Expression
J Natl Cancer Inst, March 17, 1999; 91(6): 512 - 523.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
F. Kari, G. Hatch, R. Slade, K. Crissman, P. P. Simeonova, and M. Luster
Dietary Restriction Mitigates Ozone-induced Lung Inflammation in Rats: A Role for Endogenous Antioxidants
Am. J. Respir. Cell Mol. Biol., December 1, 1997; 17(6): 740 - 747.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
S. K. Clinton, A. L. Mulloy, S. P. Li, H. J. Mangian, and W. J. Visek
Dietary Fat and Protein Intake Differ in Modulation of Prostate Tumor Growth, Prolactin Secretion and Metabolism, and Prostate Gland Prolactin Binding Capacity in Rats
J. Nutr., February 1, 1997; 127(2): 225 - 237.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. B. Tillman, J. M. Dhahbi, P. L. Mote, R. L. Walford, and S. R. Spindler
Dietary Calorie Restriction in Mice Induces Carbamyl Phosphate Synthetase I Gene Transcription Tissue Specifically
J. Biol. Chem., February 16, 1996; 271(7): 3500 - 3506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.